We are live on ! Find out more
BOCH

Blue Owl Capital Holdings Portfolio holdings

AUM $372M
1-Year Est. Return 78.25%
This Fund
S&P 500
This Quarter Est. Return
+12.37%
1 Year Est. Return
+78.25%
3 Year Est. Return
+112.77%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$310M
AUM Growth
-$220K
Cap. Flow
-$11.6M
Cap. Flow %
-3.74%
Top 10 Hldgs %
66.11%
Holding
86
New
13
Increased
6
Reduced
14
Closed
14

Top Buys

Rank Stock Value
1
TEM
Tempus AI
TEM
+$4.6M
2
RARE icon
Ultragenyx Pharmaceutical
RARE
+$3.68M
3
FLD
Fold Holdings
FLD
+$3.68M
4
STWD icon
Starwood Property Trust
STWD
+$2.55M
5
BMEA icon
Biomea Fusion
BMEA
+$2.5M

Top Sells

Rank Stock Value
1
TQQQ icon
ProShares UltraPro QQQ
TQQQ
+$10M
2
CMPS
Compass Pathways
CMPS
+$3.41M
3
ETWO
E2open Parent Holdings
ETWO
+$3.3M
4
TNGX icon
Tango Therapeutics
TNGX
+$3.23M
5
CNDT icon
Conduent
CNDT
+$2.91M

Sector Composition

Rank Sector Weight
1 Healthcare 51.14%
2 Financials 31.24%
3 Technology 10.9%
4 Consumer Discretionary 5.02%
5 Real Estate 0.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PVLA
26
Palvella Therapeutics
PVLA
$2.27B
$2.82M 0.91%
125,259
-15,000
-11% -$352K
STWD icon
27
Starwood Property Trust
STWD
$6.09B
$2.64M 0.85%
+131,461
New +$2.55M
DELL icon
28
Dell
DELL
$293B
$2.56M 0.82%
+20,848
New +$2.13M
BMEA icon
29
Biomea Fusion
BMEA
$91.3M
$2.34M 0.76%
+1,300,000
New +$2.5M
ADCT icon
30
ADC Therapeutics
ADCT
$144M
$1.97M 0.63%
733,568
– –
FLD
31
Fold Holdings
FLD
$24.9M
$1.92M 0.62%
+856,632
New +$3.68M
VRNA
32
DELISTED
Verona Pharma
VRNA
$1.74M 0.56%
18,347
– –
CABA icon
33
Cabaletta Bio
CABA
$455M
$1.71M 0.55%
+1,125,000
New +$1.75M
KRRO icon
34
Korro Bio
KRRO
$195M
$1.56M 0.5%
+125,000
New +$1.8M
APGE icon
35
Apogee Therapeutics
APGE
$10.2B
$1.52M 0.49%
+35,000
New +$1.33M
TTAN
36
ServiceTitan Inc
TTAN
$8.19B
$1.22M 0.39%
+11,350
New +$1.27M
EPD icon
37
Enterprise Products Partners
EPD
$81.7B
$970K 0.31%
31,290
– –
MRKR icon
38
Marker Therapeutics
MRKR
$18.7M
$848K 0.27%
554,250
– –
CMPS
39
Compass Pathways
CMPS
$1.83B
$644K 0.21%
229,914
-905,914
-80% -$3.41M
RZLV
40
Rezolve AI
RZLV
$1.09B
$559K 0.18%
181,667
– –
AMOD
41
Alpha Modus Holdings
AMOD
$22.1M
$418K 0.13%
9,852
– –
RZLVW
42
Rezolve AI Warrants
RZLVW
$5.64M
$381K 0.12%
476,685
-126,744
-21% -$61.9K
SLND.WS icon
43
Southland Holdings Warrants
SLND.WS
$294K 0.09%
860,302
– –
CAH icon
44
Cardinal Health
CAH
$55.4B
$289K 0.09%
1,718
– –
NIOBW
45
NioCorp Developments Ltd Warrant
NIOBW
$79.3M
$277K 0.09%
546,442
-220,085
-29% -$97.1K
AMODW
46
Alpha Modus Holdings Warrant
AMODW
$316K
$202K 0.07%
1,854,665
– –
SHFS icon
47
SHF Holdings
SHFS
$1.13M
$165K 0.05%
75,897
– –
BKSY.WS icon
48
BlackSky Technology Inc Warrants
BKSY.WS
$65.9K
$103K 0.03%
350,000
– –
OPTXW icon
49
Syntec Optics Holdings Warrant
OPTXW
$19.2M
$69.8K 0.02%
803,132
– –
DAVEW icon
50
Dave Inc Warrants
DAVEW
$15.1M
$52K 0.02%
28,750
– –
1
2
3 4

Similar funds

PC
Promethos Capital Boston, Massachusetts $372M AUM 23.19% 1-Year Est. Return
GIP
Gavilan Investment Partners Burlingame, California $372M AUM 6.04% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
SAAM
Solus Alternative Asset Management Summit, New Jersey $372M AUM 45.33% 1-Year Est. Return
KP
Kiltearn Partners Edinburgh, United Kingdom $372M AUM 18.16% 1-Year Est. Return
TCM
Thomist Capital Management Houston, Texas $371M AUM 77.62% 1-Year Est. Return
PAA
Peregrine Asset Advisers Portland, Oregon $371M AUM 41.36% 1-Year Est. Return
JC
Joho Capital New York $373M AUM 18.89% 1-Year Est. Return

Blue Owl Capital Holdings's Q2 2025 Portfolio in Review

As of Q2 2025, Blue Owl Capital Holdings held 86 positions worth $310M, down 0.07% from $310M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Blue Owl Capital Holdings withdrew a net $11.6M in Q2 2025, closing 14 positions and reducing 14 holdings. Its most notable exit was ProShares UltraPro QQQ, an estimated $10M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 44% a quarter earlier, followed by Financials and Technology.

Against the trend, Blue Owl Capital Holdings opened a new position in Tempus AI worth $5.09M.

  • Blue Owl Capital Holdings's largest Q2 2025 buy was Tempus AI: 80,167 shares worth $5.09M.
  • Blue Owl Capital Holdings added most to Ultragenyx Pharmaceutical in Q2 2025, an estimated $3.68M increase.
  • Blue Owl Capital Holdings's biggest Q2 2025 reduction was Compass Pathways, cutting an estimated $3.41M.
  • Blue Owl Capital Holdings fully exited ProShares UltraPro QQQ in Q2 2025, selling an estimated $10M.
  • Blue Owl Capital Holdings's ten largest holdings make up 66% of its $310M portfolio in Q2 2025.
  • Blue Owl Capital Holdings opened 13 new positions and closed 14 in Q2 2025.
  • Blue Owl Capital Holdings's portfolio value fell 0.07% quarter-over-quarter to $310M.

Based on Blue Owl Capital Holdings's 13F filing for Q2 2025, filed 11 Aug 2025.